background
background
MDGL
Madrigal Pharmaceuticals Inc
$275.26
+5.33
+1.97%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Thursday
May 1, 2025
7:00 AM ET
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
Friday
April 18, 2025
8:00 AM ET
Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025
Wednesday
February 26, 2025
7:00 AM ET
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Wednesday
February 12, 2025
8:00 AM ET
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025